SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-19-002011
Filing Date
2019-01-30
Accepted
2019-01-30 18:38:37
Documents
2
Period of Report
2019-01-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 3677
2 EXHIBIT 24 ex24.htm EX-24 10709
  Complete submission text file 0001140361-19-002011.txt   15884
Mailing Address C/O KINIKSA PHARMACEUTICALS, LTD. CLARENDON HOUSE, 2 CHURCH STREET HAMILTON D0 HM11
Business Address
BOESS CARSTEN (Reporting) CIK: 0001277495 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36829 | Film No.: 19553216

Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Issuer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences